Skip to main content
Figure 5 | Stem Cell Research & Therapy

Figure 5

From: Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages

Figure 5

Experimental schedule of macrophage depletion 24 hours after rhabdomyolysis. A bolus of 100 μL/10 g body weight of liposomal-encapsulated clodronate (LC) was injected into MSC-treated AKI mice to deplete M2-polarised macrophages, and a liposomal vehicle (LV) was administered as a control. AKI, acute kidney injury; MSC, mesenchymal stem cells.

Back to article page